NCT03444571

Brief Summary

Implantation of joint prostheses is currently the second largest diagnosis-related group in the Danish health service, and in view of the demographic development and spread of lifestyle diseases, this type of intervention is expected to continue to increase. Unfortunately, 5% of patients experience significant discomforts and complications. The second most frequent and serious complication is infection. While the established laboratory analyses (culture of tissue biopsies) are good at diagnosing acute infections, they are not satisfactory to diagnose a large group of patients especially with chronic infections. This can lead to prolonged diagnosing time and even to wrong diagnosis. Several studies have shown that analyses of prosthetic parts and the use of molecular biological methods for detecting infecting microorganisms can significantly improve diagnostics accuracy. The purpose of this project is primarily to demonstrate that analyses of bacterial specific DNA (16S rRNA genes) can confirm or rule out infection as fast (or faster) as cultivation methods. Rapid clarification can promote targeted treatment and in order to demonstrate this, the trial is conducted as a randomized study. .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2018

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 23, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

February 23, 2018

Status Verified

February 1, 2018

Enrollment Period

1.2 years

First QC Date

February 19, 2018

Last Update Submit

February 19, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improved diagnostic accuracy

    DNA based method can detect patients with hidden chronic infections more often than culture

    6 months post surgery

Study Arms (2)

Control

NO INTERVENTION

DNA based diagnosis

EXPERIMENTAL
Procedure: revision surgery

Interventions

If DNA based diagnosis detects infection, standard revision surgery will be conducted

DNA based diagnosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • revision of hip platelets (THA) or knee replacement (TKA) on indication of likely infection

You may not qualify if:

  • surgery within the last 4 months. The same applies to patients with short history of illness, pronounced acute symptoms and systemic response (reducing the likelihood of biofilm infection).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthopedic surgery

Aalborg, Northern Jutland, 9000, Denmark

RECRUITING

MeSH Terms

Conditions

Prosthesis-Related Infections

Interventions

Reoperation

Condition Hierarchy (Ancestors)

InfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Central Study Contacts

Yijuan Xu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Doc

Study Record Dates

First Submitted

February 19, 2018

First Posted

February 23, 2018

Study Start

February 16, 2018

Primary Completion

May 1, 2019

Study Completion

December 1, 2019

Last Updated

February 23, 2018

Record last verified: 2018-02

Locations